A Retrospective Study on Unveiling Demographic Trends and Clinical Significance for COVID-19 Patients in Tobruk City Hospital.
DOI:
https://doi.org/10.54361/LJM18.10Keywords:
COVID-19, Pandmic, respiratory infection, COVID-19 clinical traitsAbstract
This study investigates the impact of COVID-19 within the Tobruk Medical Center community, focusing on prevalence, clinical traits, and mortality rates. A comprehensive analysis was conducted on a cohort of 435 COVID-19 positive hospitalized patients from 2020 to 2022.Result Our findings reveal a higher incidence of COVID-19 among men, particularly in the 60-80 age group. Notable comorbidities, including diabetes and hypertension, underscore the vulnerability of individuals with underlying health conditions. Mortality rates, slightly higher at Tobruk Medical Center, show overlapping confidence intervals, emphasizing the need for cautious interpretation.Conclusion
The study provides crucial insights into demographic patterns and comorbidities affecting COVID-19 outcomes. The identification of risk factors, particularly the significant role of diabetes, contributes to our understanding of underlying health conditions in managing cases. Despite a slightly higher mortality rate at the medical center, the non-significant difference highlights the importance of considering potential limitations. This research contributes valuable information for guiding public health decisions and future pandemic responses, emphasizing the need for targeted interventions for at-risk populations.In conclusion, our study offers a nuanced understanding of the impact of COVID-19, providing essential knowledge to healthcare practitioners, policymakers, and researchers addressing the ongoing challenges posed by the pandemic.
Downloads
References
Shang J, Wang Q, Zhang H, et al. The relationship between diabetes mellitus and COVID-19 prognosis: A Retrospective Cohort Study in Wuhan, China. American Journal of Medicine. 2021;134(1). doi:10.1016/j.amjmed.2020.05.033
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5
Guan W jie, Ni Z yi, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
Goudouris ES. Laboratory diagnosis of COVID-19. J Pediatr (Rio J). 2021;97(1). doi:10.1016/j.jped.2020.08.001
Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4). doi:10.1016/j.dsx.2020.05.013
Costa FF, Rosário WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(5). doi:10.1016/j.dsx.2020.06.016
Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318(5). doi:10.1152/ajpendo.00124.2020
Chen Y, Yang D, Cheng B, et al. Clinical Characteristics and Outcomes of Patients with Diabetes and COVID-19 in Association with Glucose-Lowering Medication. Diabetes Care. 2020;43(7). doi:10.2337/dc20-0660
Rodilla E, Saura A, Jiménez I, et al. Association of hypertension with all-cause mortality among hospitalized patients with COVID-19. J Clin Med. 2020;9(10). doi:10.3390/jcm9103136
Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19. Circ Res. 2021;128(7). doi:10.1161/circresaha.121.318054
Lau ES, McNeill JN, Paniagua SM, et al. Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry. PLoS One. 2021;16(4):e0250774-. https://doi.org/10.1371/journal.pone.0250774
Kragholm K, Andersen MP, Gerds TA, et al. Association between male sex and outcomes of coronavirus disease 2019 (COVID-19)—A Danish Nationwide, Register-based Study. Clinical Infectious Diseases. 2021;73(11):e4025-e4030. doi:10.1093/cid/ciaa924
Doerre A, Doblhammer G. The influence of gender on COVID-19 infections and mortality in Germany: Insights from age- and gender-specific modeling of contact rates, infections, and deaths in the early phase of the pandemic. PLoS One. 2022;17(5 May). doi:10.1371/journal.pone.0268119
Kim L, Garg S, O’Halloran A, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clinical Infectious Diseases. 2021;72(9):e206-e214. doi:10.1093/cid/ciaa1012
Marand AJB, Bach C, Janssen D, et al. Lower urinary tract signs and symptoms in patients with COVID-19. BMC Infect Dis. 2021;21(1). doi:10.1186/s12879-021-06394-z
Tristão LS, Bresler R, Modesto VA, de Carvalho Fernandes R, Bernardo WM. Urological complications of COVID-19: a systematic review. International Braz J Urol. 2023;49(1). doi:10.1590/S1677-5538.IBJU.2022.0281
Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1). doi:10.1186/s12889-020-09826-8
Rodriguez-Diaz CE, Guilamo-Ramos V, Mena L, et al. Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics. Ann Epidemiol. 2020;52. doi:10.1016/j.annepidem.2020.07.007
Yanai H. Metabolic Syndrome and COVID-19. Cardiol Res. 2020;11(6). doi:10.14740/cr1181
Tandogdu Z, Cai T, Koves B, Wagenlehner F, Bjerklund-Johansen TE. Urinary Tract Infections in Immunocompromised Patients with Diabetes, Chronic Kidney Disease, and Kidney Transplant. Eur Urol Focus. 2016;2(4). doi:10.1016/j.euf.2016.08.006
Mallick U. Hypertension in CoViD19. In: Cardiovascular complications of COVID-19. ; 2022. doi:10.1007/978-3-030-90065-6_13
Drager LF, Pio-Abreu A, Lopes RD, Bortolotto LA. Is Hypertension a real risk factor for poor prognosis in the COVID-19 Pandemic? Curr Hypertens Rep. 2020;22(6). doi:10.1007/s11906-020-01057-x
Peng M, He J, Xue Y, Yang X, Liu S, Gong Z. Role of hypertension on the severity of COVID-19: A Review. J Cardiovasc Pharmacol. 2021;78(5). doi:10.1097/FJC.0000000000001116
Kwon CY, Lee B, Chung SY, Kim JW, Kim SH. Oriental herbal medicine for insomnia in the elderly with hypertension A systematic review protocol. Medicine (United States). 2018;97(36). doi:10.1097/MD.0000000000012200
Ren J, Pang W, Luo Y, et al. Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality. Journal of Allergy and Clinical Immunology: In Practice. 2022;10(1). doi:10.1016/j.jaip.2021.10.049
Published
Issue
Section
License
Copyright (c) 2024 Ghareeb emraj ghareeb , Mabroka Fathy, Ahmed saeid safaiddin, Mhuanad Jummah, Manal Abdelfattah Muhammed (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
